These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25612678)

  • 21. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
    Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
    Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitidine chloride inhibits proliferation, induces apoptosis via the Akt pathway and exhibits a synergistic effect with doxorubicin in ovarian cancer cells.
    Ding F; Liu T; Yu N; Li S; Zhang X; Zheng G; Lv C; Mou K; Xu J; Li B; Wang S; Song H
    Mol Med Rep; 2016 Sep; 14(3):2853-9. PubMed ID: 27485415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
    Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.
    Yang Z; Liu Y; Shi C; Zhang Y; Lv R; Zhang R; Wang Q; Wang Y
    Oncol Rep; 2017 Feb; 37(2):1011-1019. PubMed ID: 28075472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Khan GN; Kim EJ; Shin TS; Lee SH
    Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotinamide Overcomes Doxorubicin Resistance of Breast Cancer Cells through Deregulating SIRT1/Akt Pathway.
    Wei Y; Guo Y; Zhou J; Dai K; Xu Q; Jin X
    Anticancer Agents Med Chem; 2019; 19(5):687-696. PubMed ID: 30648523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
    Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
    Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sensitivity of PTEN gene-transfected endometrial carcinoma cell line to doxorubicin-induced apoptosis].
    Wan XY; Mao YY; Yokoyama Y
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):513-5. PubMed ID: 16438844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of doxorubicin in three-dimensional culture of breast cancer cells and the response in PI3K/AKT/PTEN signaling pathways: a pilot study.
    Gobbo MG; de Mendonça Fernandes GM; Fernandes-Ferreira R; Caires LP; Caldas HC; de Campos Zuccari DAP; Bordin-Junior NA; Gonçalves Vidotti GA; Souza DRS
    Women Health; 2022 Jul; 62(6):467-475. PubMed ID: 35681140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line].
    Ye MN; Chen HF; Zhou RJ; Liao MJ
    Zhong Xi Yi Jie He Xue Bao; 2011 Dec; 9(12):1339-46. PubMed ID: 22152773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin alleviates myocyte toxic and sensitizes anti-leukemic effect of adriamycin.
    Han Y; Yu H; Wang J; Ren Y; Su X; Shi Y
    Hematology; 2015 Jun; 20(5):276-83. PubMed ID: 25201038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway.
    Shi G; Li X; Wang W; Hou L; Yin L; Wang L
    Cell Biochem Biophys; 2024 Jun; 82(2):659-667. PubMed ID: 38411783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
    Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
    Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
    Fragni M; Bonini SA; Bettinsoli P; Bodei S; Generali D; Bottini A; Spano PF; Memo M; Sigala S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):529-38. PubMed ID: 26905520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
    Nan H; Han L; Ma J; Yang C; Su R; He J
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I; Pollak Y; Broneshter R; Iancu TC
    FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.